Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

OncoSil Files Application For Australian Manufacturing, Targets FY27 Production

OSL: $0.680 +0.00% · MC: $24M

OncoSil Medical has applied to add Cyclotek’s Macquarie Park facility to its existing certification, a step towards commercial production targeted for the second half of FY27, subject to regulatory approval. The company says the facility is designed to expand production capacity and improve manufacturing efficiency and gross margins as volumes grow, while keeping capital intensity below 5% at full capacity; Cyclotek achieved ISO 13485 certification in September.

Source announcements: 2026-11-02 08:36 to 2026-11-02 08:36 Sydney time
Story updated 2026-11-02 08:41 Sydney time
SourcesRegulatory Application Filed for Australian Manufacturing
Comments